Related Experiment Video
Updated: Aug 18, 2026

Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump
Published on: March 11, 2017
Significance of osmoticity in antibiotic small-volume parenterals
1Presbyterian Hospital of Dallas, TX 75231.
Abstract:
The most common cause of intravenous therapy morbidity is postinfusion phlebitis. It affects 25-70 percent of all hospitalized patients and can result in a prolonged stay. One potential contributing factor to postinfusion phlebitis is that most current intravenous antibiotic products and delivery systems do not consider osmolality. One important contribution hospital pharmacists can make to decreasing postinfusion phlebitis is to control final admixture osmoticity, thus ensuring that antibiotic small-volume parenterals are not causative factors. The purpose here is to discuss how changes in osmolality affect the development of postinfusion phlebitis and to provide hospital pharmacists with ideas for action to provide iso-osmotic formulations.
Insights
Postinfusion phlebitis, a common complication of intravenous therapy, can be reduced by controlling admixture osmoticity. Hospital pharmacists can help prevent this condition by ensuring antibiotic formulations are iso-osmotic.
Area of Science:
- Pharmacology
- Patient Safety
- Intravenous Therapy
Background:
- Postinfusion phlebitis is a frequent complication of intravenous therapy, impacting 25-70% of hospitalized patients.
- This condition can lead to extended hospital stays and increased healthcare costs.
- Current intravenous antibiotic products and delivery systems often overlook osmolality, a potential contributing factor.
Purpose of the Study:
- To discuss the relationship between osmolality and the development of postinfusion phlebitis.
- To provide hospital pharmacists with actionable strategies for creating iso-osmotic antibiotic formulations.
- To reduce the incidence of postinfusion phlebitis by addressing osmolality concerns.
Main Methods:
- Literature review on osmolality and phlebitis.
- Analysis of current intravenous antibiotic formulations.
- Development of recommendations for achieving iso-osmotic admixtures.
Main Results:
- Osmolality is a significant factor in postinfusion phlebitis development.
- Many antibiotic small-volume parenterals are not iso-osmotic.
- Pharmacist intervention in controlling admixture osmoticity can mitigate phlebitis risk.
Conclusions:
- Controlling final admixture osmoticity is a key role for hospital pharmacists in reducing postinfusion phlebitis.
- Implementing strategies to provide iso-osmotic formulations is crucial for patient safety.
- Addressing osmolality can decrease the morbidity associated with intravenous therapy.
Related Concept Videos
Osmosis
Tonicity in Animals
Osmosis and Osmotic Pressure of Solutions
Osmosis
Water, like other substances, moves from a high concentration of free water...
Osmotic Pressure
Factors Influencing Microbial Growth: Osmolarity

